Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment - PubMed (original) (raw)

Comparative Study

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment

K Kosaka et al. Diabetologia. 1980 Jan.

Abstract

The changes in insulin response to a 100 g glucose tolerance test after treatment by diet, sulphonylurea and insulin were compared in non-ketotic diabetic patients who had fasting blood glucose concentrations higher than 160 mg/100 ml. Patients were selected so that their pre-treatment and post-treatment blood glucose levels were comparable between different treatment groups. Their insulin responses were poor initially but increased significantly when the diabetic state was improved by each treatment. The degree of improvement of insulin response was similar between different treatment groups, when their fasting blood glucose decreased below 140 mg/100 ml and the glucose tolerance curves were improved to a similar extent. Pre- and post-treatment sigma IRI values (sum of insulin values during glucose tolerance test, mean +/- SD) were 102 +/- 50 and 200 +/- 37 microU/ml in diet-treated group (n = 28), 90 +/- 40 and 195 +/- 53 microU/ml in sulphonylurea-treated group (n = 48), and 83 +/- 28 and 193 +/- 38 microU/ml in insulin-treated group (n = 13), respectively. The data suggest that the poor insulin response in overt diabetes results not only from an inherent insensitivity of B-cells to glucose but also from the metabolic derangement of diabetes. Poor insulin response and overtly diabetic metabolism seems to form a vicious cycle.

PubMed Disclaimer

Similar articles

• Insulin secretory responses in patients with glucose intolerance due to extra-pancreatic causes. Comparison with idiopathic diabetes mellitus.
  Kosaka K, Kuzuya T, Hagura R, Akanuma Y, Kanazawa Y. Kosaka K, et al. Endocrinol Jpn. 1981 Aug;28(4):487-98. doi: 10.1507/endocrj1954.28.487. Endocrinol Jpn. 1981. PMID: 6763894
• Effect of the discontinuation of long-term sulfonylurea treatment on blood glucose and insulin secretion in noninsulin-dependent diabetes mellitus.
  Sumi S, Ichihara K, Nonaka K, Tarui S. Sumi S, et al. Endocrinol Jpn. 1982 Feb;29(1):41-7. doi: 10.1507/endocrj1954.29.41. Endocrinol Jpn. 1982. PMID: 7049684
• Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
  Lebovitz H, Feinglos MN. Lebovitz H, et al. Adv Exp Med Biol. 1979;119:371-9. doi: 10.1007/978-1-4615-9110-8_54. Adv Exp Med Biol. 1979. PMID: 495293
• Insulin secretory response in Japanese type 2 (non-insulin-dependent) diabetic patients.
  Kosaka K, Kuzuya T, Hagura R. Kosaka K, et al. Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S101-10. doi: 10.1016/0168-8227(94)90235-6. Diabetes Res Clin Pract. 1994. PMID: 7859590 Review.
• Haemoglobin A1 and diabetes mellitus.
  Gonen G, Rubenstein AH. Gonen G, et al. Diabetologia. 1978 Jul;15(1):1-8. doi: 10.1007/BF01219319. Diabetologia. 1978. PMID: 355029 Review. No abstract available.

Cited by

• Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report.
  Le Y, Zhang J, Hong T, Yang J. Le Y, et al. J Diabetes Investig. 2024 Jul;15(7):964-967. doi: 10.1111/jdi.14169. Epub 2024 Mar 2. J Diabetes Investig. 2024. PMID: 38429969 Free PMC article.
• The world congress on insulin resistance, diabetes, and cardiovascular disease (WCIRDC).
  Bloomgarden Z. Bloomgarden Z. J Diabetes. 2022 Mar;14(3):163-166. doi: 10.1111/1753-0407.13260. Epub 2022 Feb 22. J Diabetes. 2022. PMID: 35191189 Free PMC article. No abstract available.
• Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study.
  Abdelgani S, Puckett C, Adams J, Triplitt C, DeFronzo RA, Abdul-Ghani M. Abdelgani S, et al. Diabetes Obes Metab. 2021 Jul;23(7):1631-1639. doi: 10.1111/dom.14383. Epub 2021 May 6. Diabetes Obes Metab. 2021. PMID: 33852204 Free PMC article. Clinical Trial.
• Insulin Resistance versus β-Cell Failure: Is It Changing in Koreans?
  Kim MK. Kim MK. Diabetes Metab J. 2018 Apr;42(2):128-129. doi: 10.4093/dmj.2018.42.2.128. Diabetes Metab J. 2018. PMID: 29676542 Free PMC article. No abstract available.
• β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians.
  Yabe D, Seino Y, Fukushima M, Seino S. Yabe D, et al. Curr Diab Rep. 2015 Jun;15(6):602. doi: 10.1007/s11892-015-0602-9. Curr Diab Rep. 2015. PMID: 25944304 Free PMC article.

References

1. 1. Diabetologia. 1977 Dec;13(6):607-14 - PubMed
2. 1. Diabetologia. 1977 Aug;13(4):367-71 - PubMed
3. 1. Arch Intern Med. 1969 Mar;123(3):314-22 - PubMed
4. 1. Am J Physiol. 1970 May;218(5):1357-62 - PubMed
5. 1. Diabetologia. 1979 Jan;16(1):17-24 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information